Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis

Arthritis and Rheumatology

Volumn 67, Issue 1, 2015, Pages 288-295

  Wakil, Salma M ^a   Monies, Dorota M ^a   Abouelhoda, Mohamed ^a   Al Tassan, Nada ^a   Al Dusery, Haya ^a   Naim, Ewa A ^a   Al Younes, Banan ^a   Shinwari, Jameela ^a   Al Mohanna, Futwan A ^a   Meyer, Brian F ^a   Al Mayouf, Sulaiman ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

LACCASE DOMAIN CONTAINING PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG; LACCASE;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHILD; CHROMOSOME 13; CLINICAL ARTICLE; GENE MUTATION; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LINKAGE ANALYSIS; MISSENSE MUTATION; SAUDI ARABIA; ADULT; AMINO ACID SEQUENCE; EXOME; FEMALE; GENETIC LINKAGE; GENETICS; HOMOZYGOTE; INFANT; MALE; MOLECULAR GENETICS; PEDIGREE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; EXOME; FEMALE; GENETIC LINKAGE; HOMOZYGOTE; HUMANS; INFANT; LACCASE; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; SAUDI ARABIA; YOUNG ADULT;

EID: 84919946933     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38877     Document Type: Article

References (44)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. Fujikawa S, Okuni M,. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997; 39: 245-9.
3. Sawhney S, Magalhaes CS,. Paediatric rheumatology: a global perspective. Best Pract Res Clin Rheumatol 2006; 20: 201-21.
4. Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-71.
5. Fife MS, Gutierrez A, Ogilvie EM, Stock CJ, Samuel JM, Thomson W, et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther 2006; 8: R148.
6. Masters SL, Simon A, Aksentijevich I, Kastner DL,. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009; 27: 621-68.
7. Moller JC, Paul D, Ganser G, Range U, Gahr M, Kelsch R, et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 2010; 28: 912-8.
8. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887-92.
9. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
10. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 133-44.
11. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
12. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
13. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002; 46: 3340-8.
14. Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFα gene and HLA genes. Arthritis Rheum 1999; 42: 2577-82.
15. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
16. Donn RP, Shelley E, Ollier WE, Thomson W, and the British Paediatric Rheumatology Study Group. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782-5.
17. Stock CJ, Ogilvie EM, Samuel JM, Fife M, Lewis CM, Woo P,. Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immun 2008; 9: 349-57.
18. Lamb R, Thomson W, British Society of Paediatric and Adolescent Rheumatology, Ogilvie EM, Donn R,. Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 1286-91.
19. Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 1505-15.
20. Day TG, Ramanan AV, Hinks A, Lamb R, Packham J, Wise C, et al. Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 2142-6.
21. Ayaz NA, Ozen S, Bilginer Y, Erguven M, Taskiran E, Yilmaz E, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2009; 48: 23-5.
22. Rigante D, Cantarini L,. The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: comment on the review by Nigrovic [letter]. Arthritis Rheumatol 2014; 66: 2645.
23. Nigrovic PA,. Reply [letter]. Arthritis Rheumatol 2014; 66: 2645-6.
24. Ombrello MJ, Remmers EF, Tachmazidou I, Grom AA, Foll D, Martini A, et al. Genome wide association meta-analysis implicates HLA-DRB1, the BTNL2/HLA-DRA region, and a novel susceptibility locus on chromosome 1 in systemic juvenile idiopathic arthritis [abstract]. Arthritis Rheum 2013; 65 Suppl: S937.
25. Fink CW,. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995; 22: 1566-9.
26. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
27. Singh G, Athreya BH, Fries JF, Goldsmith DP,. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-9.
28. Mellins ED, Macaubas C, Grom AA,. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011; 7: 416-26.
29. Griffin TA, Barnes MG, Ilowite NT, Olson JC, Sherry DD, Gottlieb BS, et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum 2009; 60: 2113-23.
30. Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P,. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 1954-65.
31. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J,. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201: 1479-86.
32. Grom AA,. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [review]. Arthritis Rheum 2004; 50: 689-98.
33. Sakurai T, Kataoka K,. Basic and applied features of multicopper oxidases, CueO, bilirubin oxidase, and laccase. Chem Rec 2007; 7: 220-9.
34. Baldrian P,. Fungal laccases: occurrence and properties. FEMS Microbiol Rev 2006; 30: 215-42.
35. Liu H, Irwanto A, Tian H, Fu X, Yu Y, Yu G, et al. Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases. Am J Hum Genet 2012; 91: 935-41.
36. Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y, et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet 2011; 43: 1247-51.
37. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-62.
38. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-52.
39. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat Genet 2009; 41: 199-204.
40. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43: 761-7.
41. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med 2009; 361: 2609-18.
42. Schurr E, Gros P,. A common genetic fingerprint in leprosy and Crohn's disease? N Engl J Med 2009; 361: 2666-8.
43. Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001; 36: 1307-13.
44. Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW,. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol 2009; 104: 117-24.